Doctor of Nursing Practice experienced in managing complex cardiometabolic disease in high-volume primary care. Achieved cardiovascular risk reduction and improved patient outcomes through evidence-based pharmacotherapy and effective translation of clinical data into practice. Focused on supporting scientific exchange and enhancing guideline-based care adoption as a Medical Science Liaison.
Overview
16
16
years of professional experience
1
1
Certification
Work History
Primary Care Nurse Practitioner
Michigan Health Specialists
01.2010 - Current
Manage hypertension, CAD, diabetes, obesity, and dyslipidemia daily.
Prescribe and manage therapies including statins, GLP-1s, SGLT2 inhibitors, and antihypertensives.
Apply ACC/AHA and ADA guidelines to optimize cardiovascular risk reduction.
Oversaw high-volume panel of complex patients, optimizing care for cardiovascular and metabolic diseases.
Interpret labs, imaging, and risk scores to guide treatment decisions.
Converted clinical trial data into actionable treatment plans tailored for real-world patients.
Instructed patients and colleagues on emerging therapies and updates to clinical guidelines.
Identified treatment gaps and barriers to care, including cost, adherence, and access.
Navigate prior authorizations and payer requirements.
Present complex medical information in clear, actionable terms.
Build long-term trust with patients and interdisciplinary teams.
Provided mentorship to nurse practitioner students and new providers in clinical settings.
Acted as a clinical resource by providing expert guidance and support to practice staff.
Understand competitive landscape across GLP-1s, SGLT2s, statins, and emerging therapies.
Reducing Inappropriate Antibiotics for Urinary Tract Infections in Long-Term Care, Cooper, D., Petrilli, F., Shells, C., Journal of Nursing Care Quality, 2019
Relevant Experience For Msl Role
Conduct daily peer-level discussions with physicians and specialists
Present complex medical information in clear, actionable terms
Build long-term trust with patients and interdisciplinary teams
Stay current on evolving cardiovascular and metabolic treatment strategies
Understand competitive landscape across GLP-1s, SGLT2s, statins, and emerging therapies